Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Managing Antidepressant Discontinuation: A Systematic Review
Emma Maund, Beth Stuart, Michael Moore, et al.
The Annals of Family Medicine (2019) Vol. 17, Iss. 1, pp. 52-60
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes
Raymond W. Lam, Sidney H. Kennedy, G. Camelia Adams, et al.
The Canadian Journal of Psychiatry (2024) Vol. 69, Iss. 9, pp. 641-687
Open Access | Times Cited: 61
Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults
Ellen Van Leeuwen, Mieke L van Driel, Mark Horowitz, et al.
Cochrane library (2021) Vol. 2021, Iss. 4
Open Access | Times Cited: 76
Depression, antidepressants and fall risk: therapeutic dilemmas—a clinical review
Eveline P. van Poelgeest, A. C. Pronk, Didi Rhebergen, et al.
European Geriatric Medicine (2021) Vol. 12, Iss. 3, pp. 585-596
Open Access | Times Cited: 73
Strategies to reduce use of antidepressants
Tony Kendrick
British Journal of Clinical Pharmacology (2020) Vol. 87, Iss. 1, pp. 23-33
Open Access | Times Cited: 66
The ‘patient voice’: patients who experience antidepressant withdrawal symptoms are often dismissed, or misdiagnosed with relapse, or a new medical condition
Anne Guy, Marion Brown, Stevie Lewis, et al.
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 61
The relationship between dose and serotonin transporter occupancy of antidepressants—a systematic review
Anders Sørensen, Henricus G. Ruhé, Klaus Munkholm
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 192-201
Open Access | Times Cited: 42
Clinical practice guideline recommendations on tapering and discontinuing antidepressants for depression: a systematic review
Anders Sørensen, Karsten Juhl Jørgensen, Klaus Munkholm
Therapeutic Advances in Psychopharmacology (2022) Vol. 12
Open Access | Times Cited: 28
Internet and Telephone Support for Discontinuing Long-Term Antidepressants
Tony Kendrick, Beth Stuart, Hannah Bowers, et al.
JAMA Network Open (2024) Vol. 7, Iss. 6, pp. e2418383-e2418383
Open Access | Times Cited: 5
A survey of UK general practitioners about depression, antidepressants and withdrawal: implementing the 2019 Public Health England report
John Read, Julia Renton, Chris Harrop, et al.
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 38
Evaluating the Clinical Feasibility of an Artificial Intelligence–Powered, Web-Based Clinical Decision Support System for the Treatment of Depression in Adults: Longitudinal Feasibility Study
Christina Popescu, Grace Golden, David Benrimoh, et al.
JMIR Formative Research (2021) Vol. 5, Iss. 10, pp. e31862-e31862
Open Access | Times Cited: 29
“Stabilise-reduce, stabilise-reduce”: A survey of the common practices of deprescribing services and recommendations for future services
Ruth Cooper, Michael Ashman, Jo Lomani, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0282988-e0282988
Open Access | Times Cited: 11
The Primary Care Behavioral Health Model: The “Why Now?” and “How?” (Updated!)
Patricia J. Robinson, Jeffrey T. Reiter
(2025), pp. 3-33
Closed Access
Uncovering antidepressant prescription patterns: a three-year analysis of outpatient trends
Hossein Karami, Reza Mehrizi, Mohammad Effatpanah, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access
Effectiveness of rTMS compared to SSRI as early treatment of depression – study protocol of a randomized controlled trial (Early-TMS)
Julia Becker-Sadzio, Bettina Brendel, Simone Weller, et al.
European Archives of Psychiatry and Clinical Neuroscience (2025)
Open Access
A systematic review of manipulations to pharmaceutical dosage forms used in psychotropic tapering plans
Denis O’Brien, Anne Marie Healy, Andrew Harkin, et al.
British Journal of Clinical Pharmacology (2025)
Closed Access
Supporting antidepressant discontinuation: the development and optimisation of a digital intervention for patients in UK primary care using a theory, evidence and person-based approach
Hannah Bowers, Tony Kendrick, Marta Glowacka, et al.
BMJ Open (2020) Vol. 10, Iss. 3, pp. e032312-e032312
Open Access | Times Cited: 25
Harmonized Outcome Measures for Use in Depression Patient Registries and Clinical Practice
Richard E Gliklich, Michelle B Leavy, Lisa Cosgrove, et al.
Annals of Internal Medicine (2020) Vol. 172, Iss. 12, pp. 803-809
Closed Access | Times Cited: 24
Newer generation antidepressants and withdrawal effects: reconsidering the role of antidepressants and helping patients to stop
Mark Horowitz, Michael Wilcock
Drug and Therapeutics Bulletin (2021) Vol. 60, Iss. 1, pp. 7-12
Closed Access | Times Cited: 22
Self-reported reasons for reducing or stopping antidepressant medications in primary care: thematic analysis of the diamond longitudinal study
Amy Coe, Jane Gunn, Susan Fletcher, et al.
Primary Health Care Research & Development (2023) Vol. 24
Open Access | Times Cited: 7
Treatment of Persistent Postural-Perceptual Dizziness (PPPD)
Aaron Trinidade, Verónica Cabreira, Diego Kaski, et al.
Current Treatment Options in Neurology (2023) Vol. 25, Iss. 9, pp. 281-306
Closed Access | Times Cited: 7
Recovery from recurrent depression with mindfulness-based cognitive therapy and antidepressants: a qualitative study with illustrative case studies
Alice Tickell, Richard Byng, Catherine Crane, et al.
BMJ Open (2020) Vol. 10, Iss. 2, pp. e033892-e033892
Open Access | Times Cited: 19
Exploration of GP perspectives on deprescribing antidepressants: a qualitative study
Dervla Kelly, Justin Graffi, Maria Noonan, et al.
BMJ Open (2021) Vol. 11, Iss. 4, pp. e046054-e046054
Open Access | Times Cited: 16
Antidepressant discontinuation syndrome: A state-of-the-art clinical review
Michele Fornaro, C Cattaneo, Domenico De Berardis, et al.
European Neuropsychopharmacology (2022) Vol. 66, pp. 1-10
Open Access | Times Cited: 12
Deprescribing for all: a narrative review identifying inappropriate polypharmacy for all ages in hospital settings
Ali Elbeddini, Monakshi Sawhney, Yasamin Tayefehchamani, et al.
BMJ Open Quality (2021) Vol. 10, Iss. 3, pp. e001509-e001509
Open Access | Times Cited: 15
Consequences of Recurrence of Major Depressive Disorder: Is Stopping Effective Antidepressant Medications Ever Safe?
Jennifer Severe, John F. Greden, Priyanka Reddy
FOCUS The Journal of Lifelong Learning in Psychiatry (2020) Vol. 18, Iss. 2, pp. 120-128
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top